Activation of inflammatory pathways such as NF-κB and STAT3 not only promotes glioma cell invasion and angiogenesis but also sustains the stem-like properties of glioma stem-like cells (GSCs), ultimately contributing to tumor recurrence and poor prognosis (37, 38). The gene discussed is STAT3; the disease is central nervous system cancer.